Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Schiano · SciRah

Researcher profile · Semantic Scholar

J. Schiano

Share profile

J. Schiano — researcher profile on SciRah

h-index: 14
Works: 42
Citations: 711

Most-cited papers

Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin’s lymphoma responding to prior salvage therapy
R. Devillier, D. Coso, L. Castagna, Isabelle Brenot Rossi +9 more
2012Haematologica117 citations Open access
Semantic Scholar
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.
C. Laurent, A. Nicolae, C. Laurent, F. Le Bras +31 more
2019Blood114 citations Open access
Semantic Scholar
Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group.
F. Peyrade, S. Bologna, V. Delwail, J. Emile +16 more
2017The Lancet Haematology108 citations
Semantic Scholar
Measurable Residual Disease–Guided Therapy in Newly Diagnosed Myeloma
A. Perrot, J. Lambert, C. Hulin, Andréa Pieragostini +22 more
2025New England Journal of Medicine67 citations Open access
Semantic Scholar
Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation.
G. Manson, J. Mear, C. Herbaux, J. Schiano +19 more
2019European Journal of Cancer38 citations Open access
Semantic Scholar
ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells.
F. Amatore, N. Ortonne, Marc Lopez, F. Orlanducci +16 more
2020Blood Advances33 citations Open access
Semantic Scholar
EBV+ diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant-related lymphomas.
L. Mescam, V. Camus, J. Schiano, J. Adélaı̈de +15 more
2020Blood29 citations Open access
Semantic Scholar
Prolonged remissions after anti-PD-1 discontinuation in patients with Hodgkin lymphoma.
G. Manson, C. Herbaux, P. Brice, K. Bouabdallah +5 more
2018Blood28 citations
Semantic Scholar
Efficacy and safety of lenalinomide combined with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma
V. Ivanov, D. Coso, B. Chetaille, B. Esterni +7 more
2014Leukemia and Lymphoma25 citations
Semantic Scholar
A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor
R. Devillier, S. Furst, R. Crocchiolo, J. El-Cheikh +15 more
2014American journal of hematology/oncology24 citations
Semantic Scholar
“One Hour” Rituximab Infusion Is Safe and Improves Patient Care and Outpatient Unit Management.
T. Aurran-Schleinitz, G. Gravis, M. Vittot, D. Coso +6 more
200519 citations
Semantic Scholar
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group
Raphaëlle Aubrais, K. Bouabdallah, L. Chartier, C. Herbaux +22 more
2022Blood Advances18 citations Open access
Semantic Scholar
Rituximab–lenalidomide–dexamethasone induces complete and durable remission in relapsed refractory diffuse large B-cell non-Hodgkin lymphoma
V. Ivanov, E. Tabouret, G. Chuto, B. Chetaille +8 more
2010Leukemia and Lymphoma16 citations
Semantic Scholar
Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies
Aurélie Cabannes-Hamy, F. Peyrade, F. Jardin, J. Emile +17 more
2018Cancer Medicine14 citations Open access
Semantic Scholar
RAS/RAFlandscape in monoclonal plasma cell conditions.
A. Schavgoulidze, J. Corre, M. Samur, C. Mazzotti +23 more
2024Blood10 citations Open access
Semantic Scholar
Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma
G. Manson, P. Brice, C. Herbaux, M. G. Silva +14 more
2020European Journal of Nuclear Medicine and Molecular Imaging9 citations
Semantic Scholar
Large B-cell lymphomas in adolescents and young adults in comparison to adult patients: a matched-control analysis in 55 patients
D. Coso, S. Garciaz, B. Esterni, Florence Broussais-Guillaumot +8 more
2014Leukemia and Lymphoma7 citations
Semantic Scholar
GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation
F. Dachy, S. Furst, B. Calmels, T. Pagliardini +15 more
2023Bone Marrow Transplantation6 citations Open access
Semantic Scholar
Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group
Y. Al Tabaa, O. Casasnovas, C. Baillet, E. Bachy +15 more
2023Blood Advances5 citations Open access
Semantic Scholar
Pre-Phase Chemotherapy Followed By Ofatumumab (OFA) and Reduced Dose CHOP (OFA-mini-CHOP) for Patients over 80 Years with Diffuse Large B-Cell Lymphoma (DLBCL) – a Lymphoma Study Association (LYSA) Prospective Phase II Study (LNH09-7B)
F. Peyrade, Bologna Serge, V. Delwail, J. Emile +16 more
20145 citations
Semantic Scholar
Non-myeloablative conditioning regimen before T-cell replete haploidentical transplantation with post-transplant cyclophosphamide for advanced Hodgkin's and non-Hodgkin's lymphomas.
C. M. de Oca, L. Castagna, C. De Philippis, S. Bramanti +14 more
2020Biology of Blood and Marrow Transplantation4 citations Open access
Semantic Scholar
Twice‐weekly induction with ixazomib–lenalidomide–dexamethasone (IRd) combination followed by extended IRd consolidation and lenalidomide maintenance in transplant‐eligible patients with newly diagnosed multiple myeloma: Results of the phase 2 study IFM2014‐03
A. Perrot, M. Roussel, V. Lauwers-Cancès, C. Hulin +16 more
2024British Journal of Haematology3 citations Open access
Semantic Scholar
Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5‐year analysis of the French early access program (EPA)
G. Manson, C. Herbaux, J. Schiano, O. Casasnovas +15 more
2022British Journal of Haematology3 citations Open access
Semantic Scholar
[Chronic lymphocytic leukaemia: current management].
T. Aurran-Schleinitz, C. Arnoulet, V. Ivanov, D. Coso +5 more
2008La Revue de medecine interne3 citations
Semantic Scholar
Life-threatening toxicities upon Pembrolizumab intake: could pharmacokinetics be the bad guy?
Mourad Hamimed, Raynier Devillier, Pierre-Jean Weiller, Clémence Marin +5 more
2023Cancer Chemotherapy and Pharmacology2 citations Open access
Semantic Scholar
Histone deacetylase inhibitor abexinostat (S78454/PCI-24781) as a successful approach in a case of refractory peripheral angio-immunoblastic T-cell lymphoma, as a bridge to reduced intensity conditioning haplo-identical allogenic stem cell transplant
C. Saillard, J. El Cheikh, A. Granata, D. Coso +5 more
2016Leukemia and Lymphoma2 citations
Semantic Scholar
Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myeloma
R. Crocchiolo, C. Chabannon, J. El-Cheikh, B. Esterni +14 more
2013Leukemia and Lymphoma2 citations
Semantic Scholar
Irreversible parkinsonism after idecabtagene vicleucel: long-term outcome of a rare BCMA CAR T-cell neurotoxicity
G. Petrirena, J. Schiano, C. Lemarié, L. Schenone +6 more
2026Leukemia and Lymphoma1 citations
Semantic Scholar
Autologous Stem Cell Transplantation with Bendaeam (Bendamustine, Etoposide, Cytarabine, Melphalan) As Conditioning Regimen for Non-Hodgkin’s Lymphoma and Hodgkin’s Lymphoma
S. Garciaz, D. Coso, F. Broussais, J. Schiano +6 more
20141 citations
Semantic Scholar
Pilot Study of Lenalidomide-Rituximab Combination in Relapsed/Refractory Diffuse Large B Cell Lymphoma
V. Ivanov, D. Coso, T. Aurran, J. Schiano +5 more
20121 citations
Semantic Scholar
Probable disseminated cryptococcosis relapse in a patient with Hodgkin's lymphoma treated with induction therapy resumption and autologous stem cell transplant.
Hugo Bes-Berlandier, J. Stellmann, Simar Berro, B. Choufi +16 more
2026Journal de Mycologie Médicale0 citations Open access
Semantic Scholar
Farorable Outcome of Relapsed/Refractory Multiple Myeloma Treated with Idecabtagene Vicleucel (Ide-cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy; IFM Experience from the Descar-T Registry
B. Arnulf, J. Lambert, Lionel Karlin, C. Touzeau +18 more
2025Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
VALEMETOSTAT MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY RESULTS OF THE PHASE 2 VALYM STUDY FROM THE LYSA GROUP
E. Bachy, F. Bijou, S. Snauwaert, G. Damaj +23 more
2025Hematological Oncology0 citations
Semantic Scholar
Correction to: Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma
G. Manson, P. Brice, C. Herbaux, M. G. Silva +14 more
2021European Journal of Nuclear Medicine and Molecular Imaging0 citations Open access
Semantic Scholar
ICOS is widely expressed in cutaneous T-cell lymphoma and its targeting promotes potent killing of malignant cells.
F. Amatore, N. Ortonne, Marc Lopez, F. Orlanducci +14 more
2021European Journal of Cancer0 citations
Semantic Scholar
Haploidentical stem cell transplantation (Haplo-HSCT) with nonmyeloablative conditioning regimen (NMAC) and postinfusion cyclophosphamide in advanced non-Hodgkin lymphoma (NHL) patients.
S. Garciaz, L. Castagna, S. Furst, Stefania Bramenti +13 more
20140 citations
Semantic Scholar
Positron Emission Tomography Status and Tandem High-Dose Therapy Favorably Influence Outcome of Patients with Relapsed and/or Refractory Hodgkin Lymphoma
R. Devillier, D. Coso, L. Castagna, I. Brenot-Rossi +8 more
20110 citations
Semantic Scholar
574 ESTABLISHMENT AND CHARACTERISATION OF AN ALK-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA CELL LINE WITH T(2;17) LEADING TO CLTC-ALK FUSION
W. Klapper, I. Nielaender, L. Harder, R. Siebert +17 more
20080 citations
Semantic Scholar
Early Post-Transplant Administration of Recombinant Erythropoietin Decreases Transfusion Needs and Hastens Haemoglobin Reconstitution in Reduced Intensity Conditioned (RIC) Allogeneic Stem Cell Transplantation (ASCT) for Non-Myeloid Malignancies.
V. Ivanov, C. Faucher, P. Ladaique, S. Furst +8 more
20070 citations
Semantic Scholar
198: The use of recombinant human erythropoietin (rHuEpo) after reduced intensity conditioning (RIC) allogeneic hematopoietic peripheral blood stem cell transplantation (ASCT) reduces red blood cell (RBC) transfusion requirements
V. Ivanov, J. El Cheikh, C. Faucher, S. Furst +8 more
20070 citations Open access
Semantic Scholar
The Use of Recombinant Human Erythropoietin (rHuEpo) after Reduced Intensity Conditioning (RIC) Allogeneic Hematopoietic Peripheral Blood Stem Cell Transplantation (ASCT) Reduce Red Blood Cell (RBC) Transfusion Requirements.
V. Ivanov, J. El Cheikh, C. Faucher, S. Furst +8 more
20060 citations
Semantic Scholar
Stem Cell Transplantation in 281 Patients over 60 Years in Onco Hematologic Malignancies: A Single Center Experience.
A. Stoppa, N. Vey, C. Faucher, R. Bouabdallah +10 more
20040 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Bouabdallah×18
Invite
R. Bouabdallah — researcher profile on SciRah
D. Coso×17
Invite
D. Coso — researcher profile on SciRah
D. Blaise×17
Invite
D. Blaise — researcher profile on SciRah
V. Ivanov×11
Invite
V. Ivanov — researcher profile on SciRah

×9

Invite

A. Stoppa — researcher profile on SciRah

C. Chabannon×8

Invite

C. Chabannon — researcher profile on SciRah

H. Ghesquières×8

Invite

H. Ghesquières — researcher profile on SciRah

Invite

S. Furst — researcher profile on SciRah

Invite

C. Herbaux — researcher profile on SciRah

Invite

R. Houot — researcher profile on SciRah

Invite

A. Granata — researcher profile on SciRah

R. Devillier×6

Invite

R. Devillier — researcher profile on SciRah